BAMF Health Radiopharmacy
We are committed to enhancing patient access to novel radiopharmaceuticals. By fostering robust partnerships with leading pharmaceutical companies, we’re integrating commercial production with clinical trial research at one of the world’s most advanced facilities.
Our state-of-the-art radiopharmacy is equipped with dual cyclotrons, a solid target system, and multiple synthesis platforms, enabling the production of a broad spectrum of PET isotopes. From the initial stages of preclinical development through to commercial release, our expert CDMO team excels in delivering high-volume production with optimal efficiency.
Contract Manufacturing
BAMF Health is driven to make precision medicine accessible to all. Our unmatched flexibility and capacity enable best-in-class availability of unique tracers. By offering the ideal production schedule for your products, we not only accelerate patient access post-FDA approval but also help enhance the speed of market adoption.
We offer comprehensive support for both clinical trial manufacturing and commercial production. Our approach results in seamless transitions from development to delivery, optimizing the impact of your innovations in patient care.
Radiochemistry Development
We understand the importance of a dedicated and experienced team to successfully launch your asset. From the outset, we provide you with a specialized tech transfer team focused on developing, producing, and validating your product.
Leveraging our robust industry partnerships and extensive networks, we streamline processes and regulatory approvals, ensuring swift and successful clinical adoption of your asset.
Radiopharmacy Leadership Team
Join the Radiopharmacy Team
Join us and be part of a growing team of pharmacists, radiochemists, radiation safety experts, and specialists. Our unique setup places our state-of-the-art radiopharmacy right next to our Molecular Imaging Clinic and Molecular Therapy Clinic, giving you the opportunity to engage with the entire spectrum of radiopharmaceutical services—from development to patient care. Build a rewarding career and advance patient access to potentially life-saving therapies all at the same time.
Our Latest News
PET Imaging Pioneer Dr. Abass Alavi Makes $100K Donation to BAMF Health Foundation (FMAB)
Dr. Abass Alavi, a pioneering figure in the field of molecular imaging and nuclear medicine, and his wife Jane Alavi, made a $100,000 donation to our Foundation.
February 13, 2025
Infused with Possibility: Alzheimer’s Patient Shares Treatment Experience
BAMF Alzheimer’s patient says he feels privileged to come here and adds, “Now I have a shot.”
February 4, 2025
Fueled by Hope and the Open Road
David was the first person in the United States to receive a new experimental agent to treat pancreatic cancer.
January 22, 2025